Quest Diagnostics Valuation
| DGX Stock | USD 163.32 0.00 0.00% |
At this time, the company appears to be overvalued. Quest Diagnostics holds a recent Real Value of $154.0 per share. The prevailing price of the company is $163.32. Our model determines the value of Quest Diagnostics from analyzing the company fundamentals such as Operating Margin of 0.14 %, shares outstanding of 111.61 M, and Return On Equity of 0.13 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Quest Diagnostics' valuation include:
Price Book 2.6628 | Enterprise Value 24.3 B | Enterprise Value Ebitda 13.6723 | Price Sales 1.8987 | Forward PE 16.4745 |
Overvalued
Today
Please note that Quest Diagnostics' price fluctuation is very steady at this time. Calculation of the real value of Quest Diagnostics is based on 3 months time horizon. Increasing Quest Diagnostics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Quest Diagnostics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Quest Stock. However, Quest Diagnostics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 163.32 | Real 154.0 | Target 146.31 | Hype 163.39 | Naive 163.35 |
The intrinsic value of Quest Diagnostics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Quest Diagnostics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Quest Diagnostics Incorporated helps investors to forecast how Quest stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Quest Diagnostics more accurately as focusing exclusively on Quest Diagnostics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Quest Diagnostics' intrinsic value based on its ongoing forecasts of Quest Diagnostics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Quest Diagnostics' closest peers.
Quest Diagnostics Cash |
|
Quest Valuation Trend
Analysing the historical paterns of Quest Diagnostics' enterprise value and its market capitalization is a good way to estimate and gauge the value of Quest Diagnostics Incorporated over time and is usually enough for investors to make rational market timing decisions.
Quest Diagnostics Total Value Analysis
Quest Diagnostics Incorporated is currently forecasted to have company total value of 24.34 B with market capitalization of 18.11 B, debt of 5.5 B, and cash on hands of 315 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Quest Diagnostics fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
24.34 B | 18.11 B | 5.5 B | 315 M |
Quest Diagnostics Investor Information
About 92.0% of the company shares are held by institutions such as insurance companies. The book value of Quest Diagnostics was currently reported as 60.8. The company has Price/Earnings To Growth (PEG) ratio of 1.89. Quest Diagnostics recorded earning per share (EPS) of 7.44. The entity last dividend was issued on the 14th of January 2025. The firm had 2:1 split on the 21st of June 2005. Based on the key indicators related to Quest Diagnostics' liquidity, profitability, solvency, and operating efficiency, Quest Diagnostics Incorporated is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Quest Diagnostics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Quest Diagnostics has an asset utilization ratio of 65.98 percent. This suggests that the Company is making $0.66 for each dollar of assets. An increasing asset utilization means that Quest Diagnostics Incorporated is more efficient with each dollar of assets it utilizes for everyday operations.Quest Diagnostics Ownership Allocation
Quest Diagnostics owns a total of 111.61 Million outstanding shares. The majority of Quest Diagnostics Incorporated outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Quest Diagnostics to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Quest Diagnostics. Please pay attention to any change in the institutional holdings of Quest Diagnostics as this could imply that something significant has changed or is about to change at the company. Please note that on May 4, 2024, Representative Earl Blumenauer of US Congress acquired under $15k worth of Quest Diagnostics's common stock.Quest Diagnostics Profitability Analysis
The company reported the last year's revenue of 9.25 B. Total Income to common stockholders was 908 M with profit before taxes, overhead, and interest of 3.47 B.Quest Diagnostics Past Distributions to stockholders
About Quest Diagnostics Valuation
Our relative valuation model uses a comparative analysis of Quest Diagnostics. We calculate exposure to Quest Diagnostics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Quest Diagnostics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 3.1 B | 2.7 B | |
| Pretax Profit Margin | 0.12 | 0.09 | |
| Operating Profit Margin | 0.14 | 0.10 | |
| Net Profit Margin | 0.09 | 0.05 | |
| Gross Profit Margin | 0.32 | 0.44 |
A single share of Quest Diagnostics represents a small ownership stake in the entity. As a stockholder of Quest, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Quest Diagnostics Dividends Analysis For Valuation
Dividends Paid is likely to rise to about 329.7 M in 2024. Dividend Yield is likely to rise to 0.02 in 2024. At this time, Quest Diagnostics' Retained Earnings are fairly stable compared to the past year. Earnings Yield is likely to rise to 0.06 in 2024, whereas Retained Earnings Total Equity is likely to drop slightly above 6.6 B in 2024.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 314 M | 329.7 M | |
| Dividend Yield | 0.02 | 0.02 | |
| Dividend Payout Ratio | 0.37 | 0.39 | |
| Dividend Paid And Capex Coverage Ratio | 1.76 | 2.95 |
There are various types of dividends Quest Diagnostics can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Quest shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Quest Diagnostics Incorporated directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Quest pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Quest Diagnostics by the value of the dividends paid out.
Quest Diagnostics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 113 M | |
| Quarterly Earnings Growth Y O Y | 0.015 | |
| Forward Price Earnings | 16.4745 |
Quest Diagnostics Current Valuation Indicators
Valuation refers to the process of determining the present value of Quest Diagnostics Incorporated and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Quest we look at many different elements of the entity such as Quest's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Quest Diagnostics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Quest Diagnostics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Quest Diagnostics' worth.Additional Tools for Quest Stock Analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.